Cardiovascular Disease in Oklahoma
Heart Disease and Stroke Statistics for 2016
Heart Disease (including Coronary Heart Disease, Hypertension, and Stroke) remains to be the No. 1 cause of death in the US. Stroke ranks No. 5.1
Cardiovascular disease, listed as the underlying cause of death, accounts for nearly 801,000 deaths in the US. That’s about 1 of every 3 deaths in the US.1
- Coronary heart disease accounts for 1 in 7 deaths in the US, killing over 360,000 people a year.1
- In Oklahoma, heart disease was the leading cause of death, accounting for 1 in 4 deaths, killing almost 10,000 people a year.2
- Stroke accounts for 1 of every 20 deaths in the US, killing nearly 133,000 people a year.1
- In Oklahoma, stroke is the 5th leading cause of death, accounting for more than 1 in 20 deaths and killing more than 1,800 a year.2
In 2014, heart disease death rates were highest among Oklahoma non-Hispanic Blacks and American Indians. These rates were twice as high as the rate among Hispanics.2
Determining Cardiovascular Disease Risk with Cardio IQ
C-reactive protein (CRP) is made by the liver in response to tissue injury, infection, and inflammation. High levels indicate inflammation due to infection or tissue injury. Moderately elevated levels may be associated with increased heart disease risk.5 Certain medications and food may anti-inflammatory benefits.
Cardio IQ hs-CRP Test Code: 91737 CPT Code: 86141
Lp-PLA2 is an enzymatic, specific marker for vascular inflammation and is believed to contribute to plaque development.6,7 High levels of Lp-PLA2 may predict risk of a heart attack or stroke. Certain medications can reduce levels of Lp-PLA2.
Cardio IQ Lp-PLA2 Activity Test Code: 94218 CPT Code: 83698
Cardio IQ Lipid Panel is a panel of blood tests that serves as an initial broad medical assessment tool for abnormalities in Total Cholesterol, HDL Cholesterol, Triglycerides, LDL-Cholesterol (calculated), Cholesterol/ HDL Ratio (calculated). A Lipid Panel is used to identify hyperlipidemia which may indicate an increased risk for cardiovascular disease. If the Triglyceride level is greater than 400 mg/dL, a measure of Direct LDL is done. The LDL direct test, unlike what is reported in the chemistry profile, is not a calculation but rather a direct test for the best evaluation and monitoring of this risk factor.
Cardio IQ Lipid Panel w/ Direct LDL Reflex Test Code: 92061 CPT Code: 80061
Cardio IQ Lipid Panel Test Code: 91716 CPT Code: 80061
Ion Mobility Lipoprotein Fractionation is a technology that uses gas-phase (laminar flow) electrophoresis to separate unmodified lipoproteins on the basis of size. Following the separation, each lipoprotein particle is directly detected and counted as it exits the separation chamber. Proprietary test.
Cardio IQ Ion Mobility Test Code: 91604 CPT Code: 83704
QuestDirect’s Heart Health tests are available to patients without a health care provider's order.
The cholesterol panel, also known as a lipid panel, is made up of a group of tests to detect the risk of coronary artery disease, heart attack or stroke. It is also used to monitor treatment for someone already diagnosed with cardiac issues. It measures total cholesterol, HDL, LDL, and triglycerides.
A total cholesterol test is used to screen for the risk of developing heart disease. Because high blood cholesterol has been associated with the hardening of arteries, called atherosclerosis, and an increased risk of death from heart attacks, cholesterol testing is considered a routine part of preventative health care.
An inflammation marker test, also known as a high-sensitivity CRP is a blood test that is used to evaluate the risk of cardiovascular disease, heart attacks and strokes. The test measures low levels of CRP in the blood to identify low levels of inflammation that can lead to heart disease.
Important: Patients are always incouraged to discuss QuestDirect testing results with a healthcare provider.
CVD Treatment Cost
About 92.1 million American adults are living with some form of cardiovascular disease or the after-effects of stroke. Direct and indirect costs of cardiovascular diseases and stroke are estimated to total more than $316 billion, which includes both health expenditures and lost productivity.1
Heart attacks ($11.5 billion) and Coronary Heart Disease ($10.4 billion) were 2 of the 10 most expensive hospital principal discharge diagnoses.3
Between 2013 and 2030, medical costs of Coronary Heart Disease are projected to increase by about 100%.3
References
- Retreived from http://professional.heart.org/professional/ScienceNews/UCM_491264_Heart-Disease-and-Stroke-Statistics---2017-Update.jsp
- Retreived from https://www.ok.gov/health/Wellness/Chronic_Disease_Service/Heart_Disease_&_Stroke/
- Retreived from https://nccd.cdc.gov/DHDSPAtlas/Reports.aspx
- Prevalence data are from the Behavioral Risk Factor Surveillance System (BRFSS). *2013 data
- Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56:e50-103.
- Davidson MH, Corson MA, Alberts MJ, et al. Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines. Am J Cardiol. 2008;101(suppl):51F-57F.
- Gonçalves I, Edsfeldt A, Ko NY, et al. Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation. Arterioscler Thromb Vasc Biol. 2012;32:1505-1512.
Diagnostic Laboratory of Oklahoma (DLO) strives to empower patients to take a more active role in their healthcare decisions through providing education on disease states and available diagnostic testing, as well as resources for additional information from medical organizations.
